NLRP3 and stroke disorder: Recently, it has been shown that A151, a synthetic oligodeoxynucleotide containing multiple telemeric TTAGGG motifs, reduces ischemic brain damage and NLRP3 mRNA levels in Stroke-Prone Spontaneously Hypertensive rats submitted to permanent middle cerebral artery occlusion [51].